NCT02810119View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Conjunctivochalasis
Interventions
DRUG

LO2A

DRUG

Placebo

Trial Locations (1)

Unknown

Barzilai MC, Ashkelon

All Listed Sponsors
lead

Ocuwize LTD

INDUSTRY

NCT02810119 - To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis | Biotech Hunter | Biotech Hunter